Skip to main content
Clinical Trials/NL-OMON40607
NL-OMON40607
Completed
Not Applicable

Hyperinflation in COPD exacerbations - Hyperinflation in COPD exacerbations

niversitair Medisch Centrum Groningen0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male or Female, 40 years or older
  • Doctor\*s diagnosis of COPD.
  • Experiencing an exacerbation of COPD requiring hospitalization at the moment of inclusion. An exacerbation is defined as a worsening of respiratory symptoms from the stable state and beyond normal day\-to\-day variations, which requires additional treatment.
  • Patients must be able to understand and complete protocol requirements, Instructions and questionnaires in Dutch
  • Written Informed consent

Exclusion Criteria

  • If any of these criteria are absent at admission, but occur during the course of the study, patients will be followed up within the protocol as much as possible.
  • Pneumonia confirmed with X ray
  • COPD exacerbation requiring (non) invasive ventilation or admittance to an intensive care unit
  • Patient who received any investigational new drug within the last 4 weeks prior to admission or twice the duration of the biological half\-life of any investigational new drug (whichever is longer).
  • Unstable angina pectoris or other clinically important cardiac co\-morbidity requiring admission on a cardiology ward

Outcomes

Primary Outcomes

Not specified

Similar Trials